Pancreatic cancer clinical trials: how to find a study that fits
A useful pancreatic cancer trial search starts with your diagnosis, disease stage, previous treatment and current health. Biomarkers may narrow the search further. Trials can be relevant before surgery, after surgery or in advanced disease, but each has its own eligibility rules. A registry entry is a starting point; the study team must confirm the active site, available cohort and individual screening requirements.
On this page
Start with the disease setting
A study for resectable pancreatic cancer may ask a different question from a study for metastatic disease after chemotherapy. The pathology also matters: pancreatic adenocarcinoma and pancreatic neuroendocrine tumors should not be combined in one undifferentiated search.
Write down the diagnosis, stage or resectability category and the date of the most recent imaging. For a postoperative study, add the operation date and pathology findings. These details help remove studies that are clearly outside your situation before you spend time contacting sites.
Previous treatment often determines eligibility
Trials may require no previous treatment for metastatic disease or may be intended for people whose cancer has progressed after certain medicines. A study can also exclude previous exposure to a particular drug class. Treatment dates and reasons for stopping therefore matter.
Prepare a timeline with drug names, cycles, response and major side effects. Include radiation and operations. Ask your oncologist how quickly a decision is needed so a search can proceed without leaving an urgent treatment problem unresolved.
Sources and references: [2]
Use the exact biomarker result
Some studies select patients by a mutation, fusion or other tumor characteristic. A broad phrase such as KRAS-positive may be insufficient if the study requires a particular variant. Germline and tumor BRCA findings may also be treated differently by a protocol.
Send the full laboratory report when a site requests it. Ask whether existing tissue is enough or whether central confirmation or a fresh biopsy is needed. A matching marker is only one part of eligibility; it does not replace the stage, treatment and health requirements.
Keep a traceable shortlist
NCI's pancreatic cancer trial pages and ClinicalTrials.gov can help identify registered studies. Record the registry ID, study title, phase, treatment arms, location and the date you checked the entry. A hospital or sponsor may provide additional contact information.
For a possible Shanghai study, confirm the actual local site and cohort with its research team. Ask whether that site is accepting inquiries and what information it needs for an initial review. A study recruiting somewhere in the world does not establish that every listed location has a place available.
Understand what participation means
An early-phase trial often focuses on dose, safety and preliminary activity. A randomized trial may assign participants to different treatment groups rather than let them choose the experimental drug. Ask what treatment you could receive and which alternatives are available outside the study.
Discuss the known risks and the uncertainties that the study is trying to resolve. The consent process should give you time to understand the plan and ask questions. Participation is voluntary, and the team should explain how withdrawal and subsequent care would be handled.
Sources and references: [5]
Plan for screening as a separate step
A preliminary record review may be followed by tests of blood counts, organ function, disease measurements and other protocol requirements. Some studies require time since the last treatment or recovery from earlier toxicity. The research team makes the eligibility decision.
Ask what must be completed before travel and what can only be checked at the site. Do not stop an effective treatment or change medicine timing on the basis of a registry description alone. Your treating oncologist and the study team need to coordinate the transition.
Compare the visit burden and costs
Study visits, blood tests and scans can be more frequent than ordinary care. A patient traveling from overseas needs to understand how long they must stay nearby, whether a caregiver is needed and where urgent problems will be treated.
Ask which research costs the sponsor covers and which clinical, travel or accommodation costs remain yours. Confirm language support for consent and follow-up. Put these arrangements beside the expected benefit and risks when deciding whether the study fits your priorities.
Turn the search into a focused clinical inquiry
Fudan University Shanghai Cancer Center has a pancreatic surgery team and is a relevant starting point for clarifying the appropriate pancreatic cancer service. A general hospital appointment and trial screening are separate processes.
EastMedGo can help prepare a concise clinical summary and organize an inquiry about assessment or the correct research contact. Share your pathology, treatment timeline, recent images, biomarkers and any registry IDs already identified. We can help clarify the record requirements and logistics while the research team determines whether a study is appropriate and open to your participation.
Common questions
Are clinical trials only for people who have exhausted treatment?
No. Some studies involve newly diagnosed, preoperative or postoperative disease. The appropriate timing depends on the study question and eligibility criteria.
Does a recruiting label mean I can enroll?
No. The site and relevant cohort must be active, and the study team must confirm individual eligibility. Screening can identify reasons why participation is not appropriate.
Sources and references: [2]
Can EastMedGo arrange a guaranteed trial place?
The research team controls screening and enrollment. EastMedGo can help organize records, identify the appropriate inquiry route and coordinate practical arrangements around the team's response.
Sources and references: [2]
Sources and references
- Pancreatic Cancer Clinical Trials
- Steps to Find a Clinical Trial
- Pancreatic Cancer Treatment (PDQ) – Health Professional Version
- BRCA Gene Changes: Cancer Risk and Genetic Testing
- Understanding Informed Consent Forms
- Fudan University Shanghai Cancer Center: pancreatic surgery team demonstrates robotic pancreaticoduodenectomy
Prepared with AI assistance by EastMedGo for patients comparing treatment and care options.